Administrative Core
 
 
Center Members and
Criteria for Membership


Roles of the Internal
Advisory Board


Role of the External
Advisory Board


 

 

 

 

 

 

Role of the Internal Advisory Board

The Internal Advisory Board (IAB) is comprised of the Director and Deputy Director along with senior leadership of the Disease Cores (Cardiopulmonary Disease: H. Kipen; Neurological Disease : N. Fiedler and K. Reuhl; Disorders of the Integument: J. Laskin; Environmental Cancer : C.S. Yang and M. Gallo and Facility Cores (Integrative Health Sciences Facility Core: D. Wartenberg and H. Kipen; Biological Response Indicators   Core: A. Brooks ; the Controlled Exposure Facilities: P. Lioy; Chemical Analysis:  A. K ong; Bioinformatics, Biostatistics and Computational Toxicology: P. Georgopoulos).

The IAB has been extensively involved in the development of this competing renewal application, providing advice on the final Center budget and on the use of faculty development funds. In addition, the IAB assisted in recruiting new faculty into the Center’s Disease Cores and deliberated on how best to reorganize the Facility Cores. Meetings of the Internal Advisory Board have proven critical for the identification of cross-Core opportunities within the Center and assisting in defining the comprehensive role of the new Integrative Health Sciences Facility Core. Thus, the Center is already functioning under the newly proposed organizational structure.
The IAB meets monthly to provide advice on the scientific progress and administrative activities of the Center. Formal minutes are taken at these meetings and placed on file in the Director’s office. Subjects for discussion include:

    • Progress in achieving Disease Core goals and Facility Core use and goals
    • IHSFC use, opportunities and developments
    • Establishment of new research areas
    • Identification of new faculty whose expertise could be recruited into Center research
    • Need for developing new technological capabilities
    • Equipment needs
    • Review of Pilot Project applications, outcomes and establishment of the funding priorities
    • Interactions with local community groups and with disease advocacy groups and with local, state and government agencies